Evolutionary Genomics, Inc. Stock
Stocks
FNAM
US30051F1012
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:27:27 2023-07-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.5100 USD | -27.14% |
|
+254,900.00% | +254,900.00% |
| 23-03-09 | Evolutionary Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 23-03-08 | Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 2.99M 2.61M 2.47M 2.24M 4.2M 287M 4.21M 29.54M 11.4M 146M 11.25M 11M 470M | P/E 2021 |
-1.34x | P/E 2022 | -2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.16M 5.37M 5.07M 4.61M 8.63M 591M 8.67M 60.77M 23.45M 301M 23.15M 22.63M 967M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
67.35% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -27.14% | ||
| 1 week | +254,900.00% | ||
| Current month | +254,900.00% | ||
| 1 month | +254,900.00% | ||
| 3 months | +254,900.00% | ||
| 6 months | +254,900.00% | ||
| Current year | +254,900.00% |
| 1 year | 0 | 0.51 | |
| 3 years | 0 | 0.51 | |
| 5 years | 0 | 0.9 | |
| 10 years | 0 | 5.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Walter Messier
CTO | Chief Tech/Sci/R&D Officer | 71 | 1999-12-31 |
Steve Warnecke
CEO | Chief Executive Officer | 70 | 2014-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Warnecke
CHM | Chairman | 70 | 2014-09-30 |
| Director/Board Member | 76 | 1999-12-31 | |
Mark Boggess
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/23/22 | Exercice | Chief Executive Officer | 185,715 | 2.8074% | ||
| 5/23/22 | Exercice | Founder | 278,571 | 4.2111% | ||
| 5/23/22 | Exercice | Founder | 55,714 | 0.8422% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -27.14% | +254,900.00% | +254,900.00% | +13.33% | 1.33K | ||
| +0.11% | +2.71% | +0.33% | +28.59% | 46.18B | ||
| -1.12% | +1.78% | +40.07% | +27.26% | 44.35B | ||
| -3.04% | -6.29% | +322.27% | +517.36% | 42.21B | ||
| -0.74% | +1.25% | +2.32% | +67.94% | 40.19B | ||
| -0.50% | +0.67% | +11.79% | +40.51% | 29.83B | ||
| -0.46% | +4.22% | +21.99% | +124.21% | 17.17B | ||
| -0.97% | -10.17% | - | - | 15.7B | ||
| -0.57% | +8.12% | +22.15% | +38.93% | 15.32B | ||
| -3.14% | +31.91% | -10.60% | - | 14.5B | ||
| Average | -3.61% | +4.13% | +28,367.81% | +107.27% | 26.54B | |
| Weighted average by Cap. | -1.03% | +2.74% | +65.68% | +131.93% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.79M -2.44M -2.3M -2.09M -3.91M -268M -3.93M -27.56M -10.63M -136M -10.5M -10.26M -439M | -1.93M -1.69M -1.59M -1.45M -2.71M -186M -2.72M -19.08M -7.36M -94.4M -7.27M -7.11M -304M |
| Net Debt | 3.53M 3.08M 2.91M 2.64M 4.94M 339M 4.97M 34.81M 13.43M 172M 13.26M 12.97M 554M | 3.17M 2.76M 2.61M 2.37M 4.44M 304M 4.45M 31.23M 12.05M 154M 11.9M 11.63M 497M |
Employees
3
- Stock Market
- Stocks
- FNAM Stock
Select your edition
All financial news and data tailored to specific country editions
















